Condition: Central Sensitization · Lipedema · Pain · Sponsor: Marmara University
The aim of this study is to evaluate the effect of metabolic markers (HOMA-IR, triglyceride/HDL ratio, HbA1c, waist and hip circumference measurements, BMI, etc.) on pain and central sensitization in patients diagnosed with lipedema. The primary objective is to investigate the association between metabolic markers and central sensitization. The secondary objective is to assess the relationship between metabolic markers and pain intensity, pain phenotype, and functional status.
This description comes directly from the study's public registry record.
Fatma B Akdağ · +90 537 452 96 60 · fatma.betul820@gmail.com
Yeliz Özdemir · +90 536 846 94 97 · yelizbahar1@gmail.com
Always discuss trial participation with your own doctor first.
| Marmara University Faculty of Medicine Pendik Training and Research Hospital | Istanbul, Pendik, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07468097